Condition: Lupus Nephritis · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in participants with active lupus nephritis (LN).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology | La Jolla, California, United States | Recruiting |
| UCLA Medical Center: Division of Rheumatology | Los Angeles, California, United States | Recruiting |
| of California, Irvine School of Medicine Division of Rheumatology | Orange, California, United States | Recruiting |
| University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center | San Francisco, California, United States | Recruiting |
| University of Colorado School of Medicine: Division of Rheumatology | Aurora, Colorado, United States | Recruiting |
| Yale University School of Medicine: Section of Rheumatology | New Haven, Connecticut, United States | Recruiting |
| University of Miami Miller School of Medicine: Nephrology & Hypertension Division | Miami, Florida, United States | Recruiting |
| Emory University School of Medicine: Division of Rheumatology | Atlanta, Georgia, United States | Recruiting |
| University of Chicago, Department of Medicine: Rheumatology | Chicago, Illinois, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Washington University School of Medicine in St. Louis: Division of Nephrology | St Louis, Missouri, United States | Recruiting |
| Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases | Manhasset, New York, United States | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05201469